Patent Office | FDA Emergency Use Authorization | FDA Approval
To clarify, I believe there are two prioritized programs in response to the Covid19 crisis. There is also FDA Approval
One is expedited patent review, where the Patent Office analyzes the application and grants patent protection. I do not think the Patent Office requires that NNLX's test be accurate or effective, only that it is unique and does not infringe on any other patents. Since NNLX holds the patent to its NAssay test, it is almost certain that it will receive the patent because the Viral Test is a modification of this same NAssay test.
This is distinct from the FDA emergency use authorization, where Covid19 related essentials are granted EUA and allowed into the market without extensive review.
Lastly, there is FDA approval, which is a long term process which analyses safety and effectiveness.
Let me know your thoughts...
News 
Market Data 
Discover 
AI
